Singapore markets closed

Ardelyx, Inc. (ARDX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.31-0.12 (-1.87%)
As of 10:04AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close6.43
Open6.29
Bid6.30 x 100
Ask6.34 x 2000
Day's range6.23 - 6.36
52-week range3.16 - 10.13
Volume367,552
Avg. volume5,542,791
Market cap1.468B
Beta (5Y monthly)0.82
PE ratio (TTM)N/A
EPS (TTM)-0.30
Earnings date02 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.65
  • Simply Wall St.

    Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years

    While Ardelyx, Inc. ( NASDAQ:ARDX ) shareholders are probably generally happy, the stock hasn't had particularly good...

  • GlobeNewswire

    Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

    Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, May 2, 2024, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2024. To part

  • GlobeNewswire

    Ardelyx, Inc. Reports Employment Inducement Grants

    WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on March 25, 2024, the compensation committee of the company’s board of directors granted a non-qualified stock option award to purchase 205,000 shares of its common stock and a restricted stock unit award for 160,000 shares in